Skip to main content
Top
Published in: Journal of Nuclear Cardiology 3/2008

01-05-2008 | Original Articles

Safety of regadenoson, an adenosine A2A receptor agonist for myocardial perfusion imaging, in mild asthma and moderate asthma patients: A randomized, double-blind, placebo-controlled trial

Authors: Brian R. Leaker, DM, MRCP(UK), B. O’Connor, MD, FRCP, Trevor T. Hansel, MD, FRCPath, Peter J. Barnes, DM, DSc, FRCP, Lixen Meng, MS, MPH, Vandana S. Mathur, MD, FASN, Hsiao D. Lieu, MD

Published in: Journal of Nuclear Cardiology | Issue 3/2008

Login to get access
Metadata
Title
Safety of regadenoson, an adenosine A2A receptor agonist for myocardial perfusion imaging, in mild asthma and moderate asthma patients: A randomized, double-blind, placebo-controlled trial
Authors
Brian R. Leaker, DM, MRCP(UK)
B. O’Connor, MD, FRCP
Trevor T. Hansel, MD, FRCPath
Peter J. Barnes, DM, DSc, FRCP
Lixen Meng, MS, MPH
Vandana S. Mathur, MD, FASN
Hsiao D. Lieu, MD
Publication date
01-05-2008
Publisher
Springer-Verlag
Published in
Journal of Nuclear Cardiology / Issue 3/2008
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1016/j.nuclcard.2008.02.009

Other articles of this Issue 3/2008

Journal of Nuclear Cardiology 3/2008 Go to the issue

Journal Of Nuclear Cardiology ASNC Update

Calendar

Controversies In Nuclear Cardiology: Antagonist

Molecular imaging will replace perfusion imaging: The impossible dream

Controversies In Nuclear Cardiology: Protagonist

Molecular imaging will replace myocardial perfusion imaging